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ide dismutase (ECSOD) by chondrocytes, affecting the level of antioxidant
protection in joint tissue.
Methods: Human cartilage explant cultures and primary monolayer cul-
tures were used to assess the secretion of ECSOD in basal state and in
response to IL-1 beta, with and without IL-1 receptor antagonist. ECSOD
secretion was measured with an ELISA. Simultaneous determinations of
nitrc oxide production were made using the greiss method.
Results: IL-1beta decreases secretion of EC-SOD from chondrocytes both
in explant and monolayer culture and treatment with both IL-1beta and
IL-1 receptor antagonist together restores ECSOD secretion. As previously
shown we ﬁnd that IL-1 increases nitric oxide while treatment with IL-1
receptor antagonist reduces nitric oxide production.
Figure 1. Mean EC-SOD secretion by human OA cartilage in vitro treated with IL-1beta.
Figure 2. Total nitrate/nitrite measured from OA cartilage treated with and without IL-
1beta.
Conclusions: ECSOD scavenges superoxide and prevents oxidative damage
in the joint. Cartilage tissue generates reactive oxygen species in response
to cytokines and mechanical forces leaving the tissue vulnerable to oxida-
tive damage. Chronic oxidative stress may increase cell senescence, cause
damage to structural matrix proteins and alter cell signaling pathways
leading to osteoarthritis. The ﬁnding that a key inﬂammatory cytokine
(IL-1) decreases the available antioxidant protection in the joint may
explain the progressive joint damage after inﬂammatory pathways are
activated.
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Purpose: The aim of this study was to investigate if addition of bone
morphogenetic protein (BMP)-2 to human articular chondrocytes (HACs)
could help to maintain their chondrogenic phenotype in long-term culture
conditions necessary for autologous chondrocyte implantation (ACI). We
also evaluated the potential of BMP-2 as a repair factor in combination
with collagen-based biomaterials, to extend the technique to osteoarthritic
lesions.
Methods and Material: In a ﬁrst step, HACs from 19 donors were cultured
independently, according to the procedure used for ACI. Real-time PCR and
Western blotting were used to evaluate the chondrocyte phenotype and gel
retardation assays were performed to analyze DNA binding of transcription
factors under the effect of BMP-2. Next, we evaluated the responsiveness of
HAC to BMP-2 when cultured within collagen sponges. This ﬁrst approach
was undertaken with independent cultures of three donors and the cellular
phenotype was estimated by using real-time PCR.
Results: Exogenous BMP-2 improved the chondrogenic character of HACs
when ampliﬁed over two passages in monolayer. The stimulatory effect
of BMP-2 on type II collagen expression was observed not only at the
mRNA level but also at the protein level, and this is crucial for cartilage
matrix reconstruction. Our preliminary data with HACs ﬁrst ampliﬁed in
monolayer then cultured in collagen sponges in the presence of BMP-2
have revealed that BMP-2 is able to restore COL2A1 gene expression that
was lost during the ampliﬁcation step.
Conclusions: Adding exogenous BMP-2 to HACs expanded in the con-
ditions generally used for ACI or during Matrix-associated ACI is clearly
beneﬁcial to support the chondrocytic phenotype. Importantly, no sign of
hypertrophic maturation or osteogenic induction was detected beside the
chondrogenic stimulatory effect of BMP-2. This study is the ﬁrst to reveal
the beneﬁt of adding exogenous BMP-2 to HACs as a therapeutic agent for
cartilage repair.
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Purpose: Alkaptonuria (AKU) is a rare autosomal recessive condition re-
